secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001193125-24-050659
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci prices $75.2M public offering of 16.7M shares at $4.50; net proceeds $70.2M
--------------------------------------------------------------------------------

- Offering of 16.7M shares at $4.50/share; gross proceeds ~$75.2M; net proceeds ~$70.2M.
- Underwriters granted 30-day option to purchase up to 2.505M additional shares.
- Net proceeds to fund internal asset programs, Integrated Drug Creation platform, AI/wet-lab tech, and working capital.
- Cash runway extended into first half of 2027; offering expected to close March 1, 2024.
- Joint book-running managers: Morgan Stanley and TD Cowen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000119312524050659/0001193125-24-050659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000119312524050659/d768554d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-050659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer